The FFRangio System, which uses AI to obtain fractional flow reserve (FFR) measurements from routine X-rays, is at the center of this new partnership

Anita W. Asgar, MD, director, transcatheter valve therapy research at Montréal Heart Institute, discusses advances and new technology for mitral and tricuspid valves at the 2022 Transcatheter Valve Therapies (TVT) meeting. 

The study's authors noted that the ECG acquisition technology in these wearable devices appears to be quite effective. The automated algorithms, however, could still be improved. 

The document includes updated classification to established a framework for stenosis, plaque burden and plaque modifiers, including assessment of CT-FFR or myocardial CT perfusion.

However, the study’s authors did find associations between suboptimal TAVR procedures and adverse outcomes.

Cardiologist Peter Fail, MD, discusses the idea of using shunts to form a passage that enables the left atrium to decompress at rest and during physical activity. The goal is to lower left atrial pressure in heart failure patients.

The new analysis focused on transcatheter edge-to-edge repair and left atrial appendage occlusion procedures.

“Even if we compensate for the differences in population size, the U.S. is still miles ahead when it comes to total cardiomyopathy cases," explained Walter Gabriel, MPH, an epidemiologist and analyst on the report.